Skip to main content
Log in

Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

To develop a HPLC-MS method of determining ginsenoside Rh2 in dog plasma based on solid-phase extraction for pharmacokinetic studies. Six dogs were randomly assigned to two groups, either given 0.1mg / kg dose intravenously or 1 mg / kg dose through oral gavage. Analysis using high performance liquid chromatography (HPLC) with ODS column, followed by detection with electrospray ionization(ESI) mass spectrometry(MS) in negative ion mode with 500 μM ammonium chloride in the mobile phase. The assays were validated over the concentration range of 2.0–1250.0 ng/ml in dog plasma. The intra- and inter- day precision were less than 10% in terms of RSD. The overall recovery was more than 80%. The validated assay was suitable for pharmacokinetic studies of ginsenoside Rh2 and the observed oral bioavailabilities of Rh2 were 17.6% and 24.8% for male and female dogs respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cuddy ML. (2003): Commonly used herbs. J Pract Nurs. 53Θ§5–8, 25–9.

    Google Scholar 

  2. Tatsuka M. (2001): Maeda M, Ota T. Jpn J Cancer Res. 92, Nov, 1184–9.

    Article  PubMed  CAS  Google Scholar 

  3. Kikuchi Y, Sasa H, Kita T, Hirat J, Tode T, Nagata I. (1991): Anticancer Drugs. 2, 63–7.

    Article  PubMed  CAS  Google Scholar 

  4. Park EK, Choo MK, Kim EJ, Han MJ, Kim DH. (2003): Antiallergic activity of ginsenoside Rh2. Biol Pharm Bull. 26, 1581–4.

    Article  PubMed  CAS  Google Scholar 

  5. Ushio Sankawa, Chung ki, Byung Hoon han et al. (1982): Radioimmunoassay for the determination of ginseng saponin, ginsenoside Rg1. Chem. Pharm. Bull. 30, 1907–1910

    Article  CAS  Google Scholar 

  6. Odani T, Tanizawa H, Takino Y. (1983): Chem Pharm Bull (Tokyo) 31, 292–8

    Article  CAS  Google Scholar 

  7. Li W, Fitzloff JF. (2001): J Pharm Biomed Anal 25, 257–65

    Article  PubMed  CAS  Google Scholar 

  8. Wang H, Zou H, Kong L. (1999): J Chromatogr B Biomed Sei Appl 731, 403–9

    Article  CAS  Google Scholar 

  9. Popovich DG, Kitts DD. (2004): Phytochemistry. 65, 337–44.

    Article  PubMed  CAS  Google Scholar 

  10. Yun TK, Lee YS, Lee YH. (2001): J Korean Med Sei. 16, Suppl: S6–18

    CAS  Google Scholar 

  11. Pang Huan, Wang Hai-lin, Fu Li et al. (2001): Acta Pharmaceutica Sinica, 36, 170–173

    Google Scholar 

  12. Chen SE, Sawchuk RJ, Staba EJ. American (1980): ginseng. III. Pharmacokinetics of ginsenosides in the rabbit. Eur J Drug Metab Pharmacokinet 5(3):161–8

    Article  PubMed  CAS  Google Scholar 

  13. Odani T, Tanizawa H, Takino Y. (1983): Chem Pharm Bull (Tokyo) Jan; 31, 292–8

    Article  CAS  Google Scholar 

  14. Bae EA, Han MJ, Choo MK et al. (2002): Biol Pharm Bull 25, 58–63

    Article  PubMed  CAS  Google Scholar 

  15. Ota T, Maeda M, Odashima S. (1991): Mechanism of action of ginsenoside Rh2: uptake and metabolism of ginsenoside Rh2 by cultured B16 melanoma cells. J Pharm Sei Dec; 80(12): 1141–6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xie, HT., Wang, GJ., Lv, H. et al. Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs. Eur. J. Drug Metab. Pharmacokinet. 30, 63–67 (2005). https://doi.org/10.1007/BF03226409

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03226409

Keywords

Navigation